English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/78832
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Antidepressant efficacy of Cb1 agonist Hu-210 in mice following chronic administration is not dependent on constitutive neurogenesis

AuthorsDíaz, Álvaro CSIC ORCID; Pazos, Ángel CSIC ORCID; Blanco, Helena CSIC; Valdizán, Elsa M. CSIC ORCID
Issue Date2012
Citation8th Fens Forum of Neuroscience (2012)
AbstractResearch has shown antidepressant/anxiolytic efficacy of acute cannabinoid treatment on preclinical tests. However, the behavioral effects of chronic cannabinoid administration in animal models of depression are still unknown. In the present study we have used the animal model of chronic administration of corticosterone in mice (35 μg/ml, 28days, oral ) in order to evaluate: a)the effect of chronic administration of the cannabinoid agonist HU-210 (25 μg/kg/day, i.p. 2weeks) in tests assessing anxiety- and depressive-like responses, and spatial short term memory; and b) the influence of constitutive neurogenesis on behavioral effects of HU-210, using a transgenic mouse in which ablation of glial fibrillary acidic protein (GFAP)-positive cells (thus eliminating adult neural progenitor cells) was induced by ganciclovir. Corticosterone-treated mice exhibited an anxiogenic response in the novelty-suppressed feeding (NSF, latency to feed=323.1±59.5 vs 137±14.3 seconds in control group; p< 0.01) and a depressive-like response in the sucrose preference test (>anhedonia>; %sucrose intake/total= 50.8±5.7 vs. 90.8±1.3 in control; p< 0.01). An impaired performance in the T-maze test (short-term spatial memory) was also shown in corticosterone-treated animals (%alternance= 49.7±2.7 vs 63.1±2.5 in control; p< 0.05). Chronic HU-210 reversed anxiety- (NSF, latency to feed= 174.5±30.8s; p< 0.01 vs corticosterone) and depressive-like (%sucrose=78.9±3.1%; p< 0.01 vs corticosterone) behaviors but not the impaired short term spatial memory. These effects of chronic HU-210 in the NSF (latency to feed=123.3±19.9s; p< 0.01 vs corticosterone) and sucrose (% sucrose= 78.8±1.8; p< 0.01 vs corticosterone) paradigms were still present in transgenic animals treated with chronic corticosterone. This is the first study demonstrating the anxiolytic and antidepressant actions of chronic HU-210 in a validated animal model of depression/anxiety. Our results in transgenic animals also indicate that constitutive neurogenesis might not be necessary for the behavioral effects of HU-210 in this animal model.
DescriptionTrabajo presentado al: "8th Fens Forum of Neuroscience" celebrado en Barcelon del 14 al 18 de julio de 2012.-- et al.
URIhttp://hdl.handle.net/10261/78832
Appears in Collections:(IBBTEC) Comunicaciones congresos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.